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Abstract
Summary The absolute 5-year risk of subsequent non-
vertebral fractures (NVFs) in 1,921 patients presenting with
a NVF was 17.6% and of mortality was 32.3%. These risks
were highest within the first year, indicating the need to
study which reversible factors can be targeted to immedi-
ately minimise subsequent fracture risk and mortality.
Introduction NVFs are the most frequent clinical fractures
in patients presenting at the emergency unit because of a
clinical fracture. The aim of the study was to determine the
5-year absolute risk (AR) of subsequent NVF and mortality
in patients at the time they present with a NVF.
Methods Between 1999 and 2001, 1,921 consecutive
patients 50+years from a level 1 trauma centre were
included. All NVFs were confirmed on radiograph reports,
and mortality was checked in the national obituary
database. Available potential risk factors for a subsequent
NVF and mortality (age, sex and baseline fracture location:
major—hip, pelvis, multiple ribs, proximal tibia/humerus
and distal femur; minor—all others) were expressed as
hazard ratios (HR) with 95% confidence intervals (CI)
using multivariable Cox regression analysis.
Results The AR for a subsequent NVF was 17.6% and was
related to age (HR per decade, 1.44; 95%CI, 1.29–1.60).
The AR for mortality was 32.3% and was related to age
(HR per decade, 2.59; 95%CI, 2.37–2.84), male sex (HR,
1.74; 95%CI, 1.44–2.10), major fracture at baseline (HR,
5.56; 95%CI, 3.48–8.88; not constant over time) and
subsequent fracture (HR, 1.65; 95%CI, 1.33–2.05). The
highest risks were found within the first year (NVFs, 6.4%;
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Conclusions Within 5 years after an initial NVF, nearly one
in five patients sustained a subsequent NVF and one in
three died. One third of subsequent NVFs and mortality
occurred within 1 year, indicating the need to study which
reversible factors can be targeted to immediately prevent
subsequent fractures and mortality.
Keywords Fractureincidence.Fracturerisk.Mortality.
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Introduction
A history of non-vertebral fracture (NVF) is associated with
a doubling of the risk of a subsequent fracture, and the
subsequent fracture risk is quadrupled after a vertebral
fracture [1, 2]. This subsequent fracture risk is not constant
over time and is driven by the high, three to fivefold
increase in the years immediately after a first fracture,
followed by a gradual waning off later on [3]. This has been
shown for repeat morphometric vertebral fractures [4],
subsequent clinical spine, forearm and hip fractures in
patients who were hospitalised with a vertebral fracture [5],
repeat low-trauma fractures in subjects older than 60 years
[6], repeat clinical vertebral and non-vertebral fractures
from menopause onwards [3, 7, 8] and repeat hip fractures
[9]. As a result, it has been shown in long-term follow-up
studies that 40% to 50% of all subsequent fractures occur
within 3 to 5 years after a first fracture. The clinical
implication is that patients older than 50 years presenting
w i t haf r a c t u r en e e di m m e d iate attention to reduce
reversible risk factors of a subsequent fracture. This
indicates that to undertake immediate care in fracture
patients is necessary, such as the Fracture Liaison Service,
the involvement of a fracture nurse and other initiatives in
the field of post-fracture care [10–13]. It also indicates that
treatment, which has been shown to reduce fracture risk
within short term, should be started as soon as possible in
patients with a high fracture risk [14].
An increased risk of mortality has been documented after
hip, vertebral and several non-hip, non-vertebral fractures
[15]. Similar to subsequent fracture risk, this increase in
mortality is higher immediately after fracture than later on.
In women and men older than 60 years, nearly 90% of
excess deaths related to fracture over the 18 years of
observation occurred in the first 5 years.
Of the 5-year post-fracture excess mortality, approxi-
mately one third of deaths were associated to hip, vertebral
and non-hip, non-vertebral fractures, respectively. The
major causes of death were related to cardiovascular and
respiratory comorbidity and infections [15].
NVFs are the most frequent fractures in patients
presenting at the emergency unit because of a clinical
fracture [8]. There is therefore an increasing interest on the
role of drug intervention to reduce the risk of NVFs [16]
and subsequent mortality [17]. To our knowledge, this is
the first study analysing all consecutive patients older than
50 years of age presenting with a NVF during a 5-year
follow-up. The aim of the present study was to determine
the 5-year absolute risk (AR) of subsequent NVF and
mortality after a NVF.
Materials and methods
Recruitment of patients
In this retrospective study, the hospital database code
(International Classification of Disease, ICD-9) for frac-
tures was used to recruit patients. All fractures reported in
the patients’ medical files were radiographically confirmed.
Only subsequent fractures that are reported in the same
hospital database were used for the follow-up analyses.
Whether patients were deceased during follow-up was
confirmed using the national obituary database. Inclusion
criteria for this study were the following: (1) age ≥50 years,
(2) a recent NVF between January 1999 and December
2001 and (3) living in the postal code area of Maastricht.
Patients were excluded if they had sustained a pathological
fracture. Vertebral fractures were not taken into consider-
ation. The ICD-9 was used to classify clinical fractures into
15 categories: skull, vertebra, clavicle, thorax, pelvis,
humerus, forearm, wrist, hand, hip, femur, patella, tibia/
fibula, ankle or foot. These fractures were further analysed
according to fracture location (humerus, wrist and hip) and
grouping of several locations: other, multiple simultaneous
fractures belonging to the six main NVFs (wrist, leg,
humerus, hip, pelvis or clavicle) or not [16] and into major
fractures (hip, pelvis, proximal tibia or humerus, multiple
ribs and distal femur) and minor fractures (all other
fractures) [18]. All groups are mutually exclusive and
included all patients.
Available potential risk factors for subsequent fracture
and mortality included age, sex and baseline fracture
locations [6, 15]. In this paper, we only showed the
Kaplan–Meier and Cox regression analyses with major vs.
minor fractures as baseline fracture location. To create
Table 1, we used the other classifications as mentioned
above.
Statistical analysis
Univariable Kaplan–Meier curves and univariable, multi-
variable and time-dependent Cox regression analyses were
2076 Osteoporos Int (2010) 21:2075–2082performed to determine the contribution of risk factors (age,
sex and location of the baseline fracture) to the incidence of
subsequent NVFs and mortality. Follow-up time was
defined as time between first fracture and subsequent
fracture, death or end of the study period of 5 years. With
respect to mortality, the follow-up time was defined as time
between first fracture and death or end of the study period.
Hazard ratios (HR) and 95% confidence intervals (95%CI)
were reported. Two-tailed p<0.05 was considered signifi-
cant. The Schoenfeld residuals were used to check the
assumptions of proportionality. If violated, then we used
the time-dependent Cox regression analysis to represent the
profile of the HR over time. Linearity was checked for age.
SPSS 15.0 for windows (SPSS Inc., Illinois, USA) was
used to process the data.
Results
A total of 1,921 patients aged over 50 years were included,
1,433 women and 488 men. Women were significantly
older than men (women 73.5±11.5 years and men 67.1±
12.2 years, p<0.001). The majority of the baseline fractures
occurred at the ulna/radius (number of patients = 502,
26.1%), hip (number of patients = 469, 24.4%) and other
(number of patients = 561, 29.2%; Table 1).
The patients can be categorised into the following four
groups: patients who died without (n=509) or after a
subsequent NVF (n=111) and patients still alive after
5 years of follow-up with (n=227) or without a subsequent
NVF (n=1,074; Fig. 1) during a total of 7,685 patient-
years. Clearly, the most common outcome 5 years after a
NVF is to be alive without a subsequent fracture (in 55.9%
of patients; Fig. 1).
Subsequent fractures
During the 5-year follow-up period, 338 patients had 379
subsequent NVFs, indicating an AR of 17.6% (95%CI,
15.9–19.3; Fig. 1).
Inunivariableanalysis,womensustainedsignificantlymore
subsequent fractures than men (19.3% vs. 12.7%, p=0.001;
HR, 1.54; 95%CI, 1.17–2.03). Also, increasing age (HR, per
decade, 1.49; 95%CI, 1.36–1.64) and major baseline fracture
location (HR 1.60; 95%CI, 1.29–1.98) contributed in
univariable analysis to subsequent fracture risk (Fig. 2).
Hazard ratios were similar when baseline finger and toe
fractures were excluded in the analysis (data not shown). In
multivariable analysis, only age (HR per decade, 1.44; 95%
CI, 1.29–1.60) remained a significant contributor.
Mortality
During 5 years of follow-up, a total of 620 patients died,
indicating an AR of 32.2% (95%CI, 30.1–34.3). This
number consisted of 468 (32.7%) women and 152 men
(31.1%). Univariable analysis showed a significant contri-
bution of age and baseline fracture location to mortality
incidence (p<0.001; Fig. 2). To evaluate whether patients
with a subsequent fracture had an increased risk on
mortality compared with patients without a subsequent
fracture, we used the time-dependent Cox regression
analysis. This showed, in univariable analysis, an associa-
tion (HR, 2.48; 95%CI, 2.00–3.07) between patients with a
subsequent fracture and mortality compared with patients
without a subsequent fracture.
In multivariable analysis, the incidence of mortality was
higher in men (HR, 1.74; 95%CI, 1.44–2.10) compared with
Fig. 1 Flowchart of patients included in the study
Baseline fracture location Men, N=488 (%) Women, N=1,433 (%) All N=1,921 (%)
Humerus 38 (7.8) 184 (12.8) 222 (11.6)
Wrist 69 (14.1) 433 (30.2) 502 (26.1)
Hip 115 (23.6) 354 (24.7) 469 (24.4)
Other 203 (41.6) 358 (25.0) 561 (29.2)
Multiple 63 (12.9) 104 (7.3) 167 (8.7)
6 main NVFs 341 (69.9) 1,211 (84.5) 1,552 (80.8)
No main NVFs 147 (30.1) 222 (15.5) 369 (19.2)
Major 214 (43.9) 651 (45.4) 865 (45.0)
Minor 274 (56.1) 782 (54.6) 1,056 (55.0)
Table 1 Patients according to
baseline fracture location
Osteoporos Int (2010) 21:2075–2082 2077women, corrected for age and baseline fracture location. The
HR of baseline fracture location (major/minor) was not
consistent over time. Using time-dependent Cox regression,
immediately after the baseline fracture, HR was 5.56 (95%
CI, 3.48–8.88) and declined at 37 months of follow-up to
HR 1.27 (95%CI, 0.97=1.66; p=0.077) and increased
slightly thereafter to approximately the HR at 12 months
(Table 2). Overall results of Cox regression showed that
age, male gender, a major fracture and a subsequent fracture
at baseline were independent risk factors for mortality
(Table 2).
Timing of subsequent NVF and mortality
Risk of subsequent NVF and mortality significantly changed
over time (Fig. 3). The AR for subsequent NVF was 6.4%
and progressively decreased to 3.3% in the fifth year (Fig. 3).
Of all the patients with a subsequent NVF, 36.4%
sustained a NVF within the first year. Clustering of
fractures was found at all ages in women and men and in
all subgroups of fractures.
The incidence of mortality was highest in the first year
following the baseline fracture (12.2%) and declined to 6.9%
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Fig. 2 Kaplan–Meier curves stratified by sex (univariable analysis).
A1–B1 Subsequent fracture incidence by baseline fracture location.
C1–D1 Subsequent fracture incidence by age in groups. A2–B2
Mortality incidence according to baseline fracture location. C2–D2
Mortality incidence according to age in groups. Values of p for all
comparisons were calculated with the use of the log-rank test
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Fig. 2 (continued)
Variable Hazard ratio 95%CI p value
Sex men vs. women 1.74 1.44–2.10 <0.001
Age (per decade) 2.59 2.37–2.84 <0.001
Baseline fracture location (major vs. minor)
0 months 5.56 3.48–8.88 <0.001
12 months 2.44 1.90–3.14 <0.001
24 months 1.49 1.13–1.96 0.004
36 months 1.27 0.97–1.66 0.083
48 months 1.50 1.14–1.97 0.004
60 months 2.47 1.41–4.33 0.002
Patients with a subsequent fracture vs. patients
without a subsequent fracture
1.65 1.33–2.05 <0.001
Table 2 Mortality incidence:
multivariable Cox regression
analysis with time-dependent
covariates
Osteoporos Int (2010) 21:2075–2082 2079in the fifth year (Fig. 3). Of all subsequent mortality, 37.9%
occurred within the first year. Of the patients who sustained
a hip fracture, the 1-year mortality was 40% in men and 29%
in women. At the end of the follow-up period, 302 (65%) of
the hip fracture patients at baseline were deceased.
Discussion
Based on hospital databases for radiographically diag-
nosed fractures to ascertain fractures and the national
obituary, the AR of sustaining a new NVF within 5 years
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2080 Osteoporos Int (2010) 21:2075–2082after a NVF was 17.6% and 32.3% for mortality. Until
today, no data have been published regarding subsequent
fracture risk and mortality in a patient population with all
clinical fractures (NVF) of 50 years and over with a 5-year
follow-up period. Moreover, there are no guidelines which
recommend evaluating all these patients investigated in this
research.
Remarkably, after multivariable analysis, patients sus-
taining a minor fracture had a similar risk to a subsequent
fracture as patients with a major fracture at baseline even
after a hip fracture. In addition, the same was true between
sexes: After correcting for age, subsequent fracture rate was
similar between men and women, as found by Center et al.
[6]. Even patients with a wrist fracture at baseline had an
AR of a subsequent fracture of 17.9% within 5 years of
follow-up. From a clinical point of view, these results
indicate that fracture prevention should be considered after
any fracture. Increasing age was the most important factor
for a subsequent fracture corrected for sex and baseline
fracture location. Only three variables (age, gender and
fracture location) were available, and not surprisingly, age
was the most predictive factor, as in most other fracture
prediction models. Over one third (36.4%) of the patients
sustained a subsequent NVF within the first year after their
baseline fracture. Previous studies reported similar findings.
In our own previous study, we found an absolute risk of
10.8% for sustaining any clinical subsequent fracture within
2 years after baseline fracture, with 60% occurring in the
first year after the baseline fracture [8]. Van Geel et al. [3]
found a RR of 5.3 of subsequent fracture compared with
patients without a subsequent fracture.
Similar results were reported after vertebral fractures
[19]. Center et al. showed that 41% of the women and 52%
of the men sustained their subsequent fracture within the
first 2 years after the initial fracture. The aim of this study
was not to compare subsequent fracture incidence with first
fracture incidence, as we already have shown in a
population-based study in post-menopausal women be-
tween ages 45 and 90 years from the same region that the
1-year incidence of all first fractures was 1.0%. We
recalculated the risk of only a first NVF which was 0.9%
(excluding all patients with vertebral fractures). In that
study, the first year subsequent fracture incidence was 6.0 %,
almost equal as in our study (6.8%) [3].
During the study, almost one in three patients died. Our
results confirm previous findings by others that mortality is
associated with increasing age, male gender and baseline
fracture location in a multivariable model even at the age of
50 years and over [15, 18, 20–27].
There are some potential limitations to this study. First,
due to the retrospective design of this study, we could have
missed subsequent fractures which had occurred outside the
recruitment region of the hospital. In an earlier study, <1%
of all patients presenting at the Emergency Department
were from outside the hospital region, indicating that <1%
of fractures could have been missed [8]. All fractures in the
hospital are coded (ICD-9) and stored in the hospital
database. Second, vertebral fractures were excluded because
of difficulty with verification of timing of these fractures.
Third, we have no data on the trauma mechanism. In
earlier studies, we have shown that about 20% of clinical
fractures are not resulting from a fall from maximum
standing height or lesser trauma [28]. However, Mackay
et al. [29] have shown that the risk of subsequent fractures
is similar after high- and low-energy trauma. There are no
data available for mortality after high- and low-energy
trauma in fractures.
Fourth, there are no data on the cause of death. We
therefore cannot correlate if these deaths are directly related
to the previous fracture or the subsequent fracture. The
enhanced mortality could be a sign of poor health or other
underlying conditions. Further studies will be necessary to
examine to what degree bone and extraskeletal risks are
predictive of subsequent fractures and mortality. Others
have shown that bone, fall and general health-related
factors could be involved [15].
In conclusion, we found that within 5 years after an
initial NVF, nearly one in five patients sustained a
subsequent NVF and one in three died. One third of
subsequent NVFs and mortality occurred within 1 year,
indicating the need to study which reversible factors can be
targeted to immediately prevent subsequent fractures and
mortality.
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